July 1st, 2020
Targeting both students and workers with its marketing, the company says its products can reduce or negate the effects of blue light, which it claims cause “headaches, dry eyes, eye strain, and even macular degeneration.” And while the FDA does not generally regulate eyewear, advertising that products can prevent headaches and macular degeneration is an issue the agency has taken issue with in the past, as seen in warning letters here and here.
In addition, the FTC requires advertisers to be able to substantiate their claims with adequate scientific evidence — something CalmOptics appears to lack. (While the company’s website is heavy on glowing reviews, it doesn’t provide any scientific studies to support its promising claims.)
In fact, the American Academy of Ophthalmology says that the blue light emitted from screens does next to nothing to humans.
The use of unsubstantiated health claims isn’t the only red flag with CalmOptics either. When asked by the BBB in May 2020 to substantiate a “BOGO 50% Off” advertisement, the company — which has a C- rating, an aggregate one-star customer review rating and almost a dozen complaints filed with the BBB— failed to respond to the inquiry.
TINA.org reached out to CalmOptics for comment. Check back for updates.
For more of our coverage of eyewear click here.